UK Supreme Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patents

INDIANAPOLIS, July 7, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced that the UK Supreme Court has decided in the litigation relating to alternative salt forms of Alimta® (pemetrexed disodium) that ... Biopharmaceuticals, Litigation Eli Lilly, Actavis, Alimta, pemetrexed disodium
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news